
Matchmaking at its best - matching the right person with the right #job and culture in the #biotech and #pharmaceutical arena
Scottsdale, AZ
Joined April 2013
- Tweets4.7K
- Following170
- Followers88
- Likes1
Partnered with Genentech and Microsoft, this biotech believes it can leverage its knowledge of the immune syst ... - endpts.com/partnered-with-ge…
UPDATED: Iovance comes back with another upbeat cancer trial update as #ASCO19 curtain raiser - endpts.com/iovance-comes-bac…
After generating ASCO fervor, Iovance unveils plans to build $75M cell therapy manufacturing plant - endpts.com/after-generating-…
Biomarin to seek approval for hemophilia gene therapy, but durability questions persist statnews.com/2019/05/28/biom… via @statnews
Amicus and Penn Broaden Gene Therapy Collaboration to Include 12 More Rare Diseases | BioSpace biospace.com/article/amicus-… #jobs
FDA Approves Celgene’s Revlimid for Follicular Lymphoma | BioSpace biospace.com/article/celgene… #jobs
Make that 2 prospective blockbuster approvals in 1 day for Novartis as FDA OKs targeted cancer therapy - endpts.com/make-that-2-prosp…
BREAKING: Novartis is rolling out its gene therapy Zolgensma at a price of $2.12M e.endpointsnews.com/t/t-0905…
Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm fiercepharma.com/pharma/mass…
Sobered by mounting costs, Dynavax looks to unload I/O, slash jobs and circle wagons around Heplisav - endpts.com/sobered-by-mounti…
UPDATED: Sarepta's Exondys 51 is not cost-effective, nor particularly beneficial for DMD patients — ICER - endpts.com/sareptas-exondys-…
UPDATED: Ex-FDA commish Scott Gottlieb makes a quick jump back onto the money side of biotech - endpts.com/ex-fda-commish-sc…
In a change of plans, Nektar spins out its opioid into a new biotech subsidiary as FDA PDUFA date looms - endpts.com/in-a-change-of-pl…
Array's ‘extremely compelling’ new colon cancer data spark blockbuster talk fiercepharma.com/pharma/extr…
Biotech builder ElevateBio reveals its first portfolio company: AlloVir fiercebiotech.com/biotech/bi…
Catalent's new prize, Paragon, adding capacity to make Sarepta gene therapies fiercepharma.com/manufacturi…
T3D Therapeutics Receives $9 Million NIH Grant to Advance Alzheimer's Clinical Trial | BioSpace biospace.com/article/-chroni… #jobs
UCB Wins FDA Approval for Epilepsy Treatment Acquired in $370 Million Deal | BioSpace biospace.com/article/ucb-win… #jobs
U.S. FDA labels J&J surgical staplers' recall as severest reut.rs/2LQY7qN
Ionis peeks behind the science with first official branding—30 years after its founding fiercepharma.com/marketing/i…